$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000168875723000081 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$31.56M	$38.51M	$38.25M
YoY Change	-27.97%	0.68%	31.7%
Cost Of Revenue	$10.98M	$12.45M	$12.21M
YoY Change	-29.86%	2.04%	29.58%
Gross Profit	$20.59M	$26.05M	$26.04M
YoY Change	-26.91%	0.05%	32.72%
Gross Profit Margin	65.22%	67.66%	68.09%
Selling, General & Admin	$36.88M	$39.96M	$31.27M
YoY Change	5.84%	27.8%	26.18%
% of Gross Profit	179.16%	153.39%	120.08%
Research & Development	$5.820M	$7.128M	$5.289M
YoY Change	-10.17%	34.77%	36.17%
% of Gross Profit	28.27%	27.36%	20.31%
Depreciation & Amortization	$1.222M	$700.0K	$978.0K
YoY Change	23.56%	-28.43%	3160.0%
% of Gross Profit	5.94%	2.69%	3.76%
Operating Expenses	$42.70M	$47.09M	$36.56M
YoY Change	3.33%	28.81%	27.54%
Operating Profit	-$22.11M	-$21.04M	-$10.52M
YoY Change	68.05%	100.04%	16.29%
Interest Expense	-$634.0K	$3.679M	$3.880M
YoY Change	-249.18%	-5.18%	69.21%
% of Operating Profit
Other Income/Expense, Net	-$298.0K	-$4.158M	-$3.618M
YoY Change	3625.0%	14.93%	8.36%
Pretax Income	-$23.05M	-$28.60M	-$18.01M
YoY Change	80.86%	58.87%	23.22%
Income Tax	-$2.505M	$669.0K	$603.0K
% Of Pretax Income
Net Earnings	-$20.54M	-$29.27M	-$18.61M
YoY Change	51.47%	57.31%	26.77%
Net Earnings / Revenue	-65.09%	-76.02%	-48.65%
Basic Earnings Per Share		-$1.12	-$0.76
Diluted Earnings Per Share	-$0.79	-$1.12	-$0.76
COMMON SHARES
Basic Shares Outstanding	25.81M shares	25.78M shares	24.51M shares
Diluted Shares Outstanding		26.03M shares	24.51M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.04M	$52.20M	$65.35M
YoY Change	-39.67%	-20.12%	1.12%
Cash & Equivalents	$40.04M	$52.19M	$65.35M
Short-Term Investments
Other Short-Term Assets	$7.404M	$10.80M	$1.663M
YoY Change	178.56%	549.43%	-80.94%
Inventory	$79.47M	$67.94M	$31.56M
Prepaid Expenses			$1.918M
Receivables	$46.92M	$54.69M	$31.25M
Other Receivables	$1.073M	$1.700M	$0.00
Total Short-Term Assets	$174.9M	$186.7M	$138.2M
YoY Change	16.68%	35.14%	10.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$77.21M	$72.64M	$39.21M
YoY Change	51.11%	85.25%	133.68%
Goodwill	$465.0K	$465.0K	$465.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles	$7.987M	$5.705M	$4.632M
YoY Change	73.33%	23.16%	26.77%
Long-Term Investments
YoY Change
Other Assets	$4.702M	$1.439M	$1.447M
YoY Change	264.5%	-0.55%	223.71%
Total Long-Term Assets	$93.74M	$83.81M	$49.49M
YoY Change	53.28%	69.36%	109.22%
TOTAL ASSETS
Total Short-Term Assets	$174.9M	$186.7M	$138.2M
Total Long-Term Assets	$93.74M	$83.81M	$49.49M
Total Assets	$268.6M	$270.5M	$187.7M
YoY Change	27.28%	44.17%	26.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$41.62M	$28.93M	$14.88M
YoY Change	107.77%	94.43%	45.05%
Accrued Expenses	$13.69M	$19.39M	$16.71M
YoY Change	-20.58%	16.06%	-12.89%
Deferred Revenue	$1.836M	$1.986M	$793.0K
YoY Change	8.77%	150.44%	31.51%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$57.15M	$50.30M	$32.38M
YoY Change	46.69%	55.37%	6.33%
LONG-TERM LIABILITIES
Long-Term Debt	$188.7M	$185.3M	$148.2M
YoY Change	7.57%	25.05%	188.63%
Other Long-Term Liabilities	$1.645M	$1.505M	$2.243M
YoY Change	1.17%	-32.9%	4.57%
Total Long-Term Liabilities	$190.4M	$186.8M	$2.243M
YoY Change	11608.73%	8229.29%	-95.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$57.15M	$50.30M	$32.38M
Total Long-Term Liabilities	$190.4M	$186.8M	$2.243M
Total Liabilities	$250.2M	$240.0M	$186.1M
YoY Change	14.14%	28.96%	114.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$360.1M	-$339.6M	-$268.0M
YoY Change	27.88%	26.68%	39.46%
Common Stock	$315.6M	$310.6M	$223.1M
YoY Change	41.14%	39.2%	1.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.40M	$30.49M	$1.519M
YoY Change
Total Liabilities & Shareholders Equity	$268.6M	$270.5M	$187.7M
YoY Change	27.28%	44.17%	26.49%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$20.54M	-$29.27M	-$18.61M
YoY Change	51.47%	57.31%	26.77%
Depreciation, Depletion And Amortization	$1.222M	$700.0K	$978.0K
YoY Change	23.56%	-28.43%	3160.0%
Cash From Operating Activities	-$8.148M	-$31.52M	-$21.98M
YoY Change	-41.87%	43.4%	76.48%
INVESTING ACTIVITIES
Capital Expenditures	$4.620M	$6.600M	-$4.810M
YoY Change	-55.7%	-237.21%	344.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$4.620M	-$6.600M	-$4.810M
YoY Change	-55.7%	37.21%	344.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	65.00K	480.0K	1.265M
YoY Change	-99.74%	-62.06%	-22.72%
NET CHANGE
Cash From Operating Activities	-8.148M	-31.52M	-21.98M
Cash From Investing Activities	-4.620M	-6.600M	-4.810M
Cash From Financing Activities	65.00K	480.0K	1.265M
Net Change In Cash	-12.70M	-37.64M	-25.52M
YoY Change	-2483.3%	47.46%	114.48%
FREE CASH FLOW
Cash From Operating Activities	-$8.148M	-$31.52M	-$21.98M
Capital Expenditures	$4.620M	$6.600M	-$4.810M
Free Cash Flow	-$12.77M	-$38.12M	-$17.17M
YoY Change	-47.77%	122.02%	50.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Country Region CountryRegion	506
	dei	City Area Code CityAreaCode	24
CY2023Q3	us-gaap	Cash Cash	52190000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1459000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54693000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	67935000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11903000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	186721000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72642000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	465000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4158000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3618000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2086000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2424000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-18608000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57960000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.53
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26034185	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25444155	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-29273000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-18608000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57960000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	144000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-761000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	144000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	69000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18539000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58721000	usd
	dei	Local Phone Number LocalPhoneNumber	34 2400
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Building B15 and 25
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Coyol Free Zone
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alajuela
	dei	Entity Address Country EntityAddressCountry	CR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
	dei	Trading Symbol TradingSymbol	ESTA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25808260	shares
CY2023Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5769000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19019000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60081000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1566000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-61647000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.53
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26034185	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24511495	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24511495	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25444155	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24406389	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24406389	shares
	us-gaap	Net Income Loss NetIncomeLoss	-61647000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1054000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-761000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1054000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29129000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62701000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8185000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1271000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3324000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	62000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-402000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-15996000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	84538000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	35000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	210000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3616000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	282000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-503000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16745000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	54873000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3434000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2107000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5933000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	47835000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	411000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3743000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	984000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15867000	usd
CY2022Q3	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1275000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2921000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	69000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-18608000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1519000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57960000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-61647000	usd
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2944000	usd
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2881000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	712000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	393000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1056000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1487000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10911000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10098000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-242000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-121000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	621000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-5832000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	542000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	311000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19019000	usd
	esta	Property Plant And Equipment Write Down PropertyPlantAndEquipmentWriteDown	-341000	usd
	esta	Property Plant And Equipment Write Down PropertyPlantAndEquipmentWriteDown	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	703000	usd
	esta	Stock Compensation Issued In Lieu Of Cash Fees StockCompensationIssuedInLieuOfCashFees	-70000	usd
	esta	Stock Compensation Issued In Lieu Of Cash Fees StockCompensationIssuedInLieuOfCashFees	0	usd
	esta	Interest Costs Capitalized Construction In Progress InterestCostsCapitalizedConstructionInProgress	3016000	usd
	esta	Interest Costs Capitalized Construction In Progress InterestCostsCapitalizedConstructionInProgress	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9860000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5356000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19634000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9883000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32958000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8315000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1103000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3191000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	149000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	937000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8674000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	610000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	787000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2692000	usd
	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-511000	usd
	esta	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-251000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	130000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-157000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80365000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38150000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7253000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1885000	usd
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	0	usd
	esta	Paymentsto Acquire Assets Including Receivables Held PaymentstoAcquireAssetsIncludingReceivablesHeld	525000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	370000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1209000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	12304000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	20744000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19927000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24363000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	84538000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	143593000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	71681000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2074000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3388000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	450000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	86162000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75278000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-35000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-831000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14165000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11934000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66355000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53415000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52190000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65349000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4200000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4184000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1810000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1298000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1269000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	32000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1280000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	250000	usd
	esta	Noncash Or Part Noncash Acquisition Noncash Equity Instrument Consideration NoncashOrPartNoncashAcquisitionNoncashEquityInstrumentConsideration	0	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3016000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q3	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the condensed </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company’s cash is held at two financial institutions in the United States. Balances in the Company’s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company operates, the Company uses a combination of distributors and direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s revenues were derived from the sale of Motiva Implants. During the nine months ended September 30, 2023 and 2022, no customer accounted for more than 10% of the Company’s revenue. Two customers accounted for 11.7% and 10.0% of the Company’s trade accounts receivable balance as of September 30, 2023. One customer accounted for 11.5% of the Company’s trade accounts receivable balance as of December 31, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc. (formerly NuSil Technology, LLC), or Avantor, as the sole supplier of medical-grade silicone used in Motiva Implants. During the nine months ended September 30, 2023 and 2022, the Company had purchases of $45.2 million, or 69.5% of total purchases, and $21.6 million, or 52.2% of total purchases, respectively, from Avantor. As of September 30, 2023 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had an outstanding balance owed to this vendor of $4.8 million and $5.6 million, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial condition and future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, unfavorable economic conditions, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, access to capital, strategic relationships and dependence on key individuals and sole source suppliers.</span></div>Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company is denied clearance, clearance is delayed, or the Company is unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.
CY2023Q3	esta	Number Of Financial Institutions Holding Cash NumberOfFinancialInstitutionsHoldingCash	2	financial_institution
CY2023Q3	esta	Number Of Financial Institutions Holding Cash NumberOfFinancialInstitutionsHoldingCash	2	financial_institution
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3700000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2600000	usd
	esta	Revenue From Contract With Customer Product Return Period RevenueFromContractWithCustomerProductReturnPeriod	P15D
CY2023Q3	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss	200000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38506000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P50Y
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3800000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3600000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1400000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5600000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. These reclassifications had no material impact on the Company’s financial position as of September 30, 2023 or results of operations for the three and nine months ended September 30, 2023.</span></div>
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	33147000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12549000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1356000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1666000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33432000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22368000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	67935000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	36583000	usd
CY2023Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	8000000	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2000000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	2152000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2598000	usd
CY2023Q3	esta	Prepaid Construction In Process PrepaidConstructionInProcess	39000	usd
CY2022Q4	esta	Prepaid Construction In Process PrepaidConstructionInProcess	2240000	usd
CY2023Q3	esta	Prepaid Assets PrepaidAssets	399000	usd
CY2022Q4	esta	Prepaid Assets PrepaidAssets	991000	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	1076000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1400000	usd
CY2023Q3	esta	Prepaid Services PrepaidServices	636000	usd
CY2022Q4	esta	Prepaid Services PrepaidServices	685000	usd
CY2023Q3	us-gaap	Supplies Supplies	1618000	usd
CY2022Q4	us-gaap	Supplies Supplies	433000	usd
CY2023Q3	esta	Prepaid Clinical Trial Costs Current PrepaidClinicalTrialCostsCurrent	245000	usd
CY2022Q4	esta	Prepaid Clinical Trial Costs Current PrepaidClinicalTrialCostsCurrent	300000	usd
CY2023Q3	esta	Prepaid Warranty And Distribution Rights Current PrepaidWarrantyAndDistributionRightsCurrent	253000	usd
CY2022Q4	esta	Prepaid Warranty And Distribution Rights Current PrepaidWarrantyAndDistributionRightsCurrent	238000	usd
CY2023Q3	esta	Prepaid Software PrepaidSoftware	1004000	usd
CY2022Q4	esta	Prepaid Software PrepaidSoftware	1090000	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1700000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2781000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1568000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11903000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11543000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	88255000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	64713000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15613000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13621000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72642000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	51092000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	700000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	700000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2000000	usd
CY2023Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	5170000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	5245000	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6106000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4097000	usd
CY2023Q3	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	4500000	usd
CY2022Q4	esta	Accrued Stock Option Grant Bonus Current AccruedStockOptionGrantBonusCurrent	4500000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000	usd
CY2023Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	240000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	171000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1986000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1688000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1505000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1670000	usd
CY2023Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	44000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1505000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1626000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	465000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	11866000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6161000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5705000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	9894000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5286000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4608000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	308000	usd
CY2023Q3	esta	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	608000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3984000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q3	esta	Number Of Tranches NumberOfTranches	4	tranche
	us-gaap	Operating Lease Cost OperatingLeaseCost	819000	usd
	us-gaap	Sublease Income SubleaseIncome	156000	usd
	us-gaap	Lease Cost LeaseCost	663000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3561000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	751000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2918000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3669000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.094
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.095
	us-gaap	Operating Lease Payments OperatingLeasePayments	796000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	429000	usd
	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	135000	usd
	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	0	usd
	esta	Operating Lease Payments Net Of Sublease Income OperatingLeasePaymentsNetOfSubleaseIncome	661000	usd
	esta	Operating Lease Payments Net Of Sublease Income OperatingLeasePaymentsNetOfSubleaseIncome	429000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	478000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1829000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	249000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	998000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	912000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	833000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	724000	usd
CY2023Q3	esta	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	801000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4517000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	848000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3669000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	79000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	321000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	332000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	343000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	355000	usd
CY2023Q3	esta	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	683000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2113000	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26213504	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24815908	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25805434	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24407838	shares
CY2023Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	84600000	usd
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5959808	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3971000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2921000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10911000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10097000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1873165	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.73
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47273000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	44.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	124084	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	70.08
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	89291	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	92156	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	67.12
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1815802	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	44.32
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	27364000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1128202	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	33.75
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	24500000	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	89291	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.21
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3900000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11700000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17900000	usd
	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P2Y
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-29273000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-18608000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-57960000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-61647000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26034185	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26034185	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24511495	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24511495	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25444155	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25444155	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24406389	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24406389	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.76
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.53
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1788375	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1766801	shares
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001688757-23-000081-index-headers.html	Edgar Link	pending
0001688757-23-000081-index.html	Edgar Link	pending
0001688757-23-000081.txt	Edgar Link	pending
0001688757-23-000081-xbrl.zip	Edgar Link	pending
esta-20230930.htm	Edgar Link	pending
esta-20230930.xsd	Edgar Link	pending
esta10qq32023-exhibit311.htm	Edgar Link	pending
esta10qq32023-exhibit312.htm	Edgar Link	pending
esta10qq32023-exhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
esta-20230930_cal.xml	Edgar Link	unprocessable
esta-20230930_def.xml	Edgar Link	unprocessable
esta-20230930_lab.xml	Edgar Link	unprocessable
esta-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
esta-20230930_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2023 Q4 Form 10-Q Financial Statement

#000168875723000081 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2023 Q4 Form 10-Q Financial Statement

#000168875723000081 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta